Alpha Tau Medical Ltd.
DRTS
$3.48
$0.061.75%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -- | 8.87M | 8.89M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 36.35M | 35.46M | |
| Operating Income | -- | -- | -36.35M | -35.46M | |
| Income Before Tax | -- | -- | -27.65M | -28.96M | |
| Income Tax Expenses | -- | -- | -27.00K | -4.00K | |
| Earnings from Continuing Operations | -- | -- | -27.63 | -28.95 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -27.63M | -28.95M | |
| EBIT | -- | -- | -36.35M | -35.46M | |
| EBITDA | -- | -- | -35.28M | -34.42M | |
| EPS Basic | -- | -- | -0.40 | -0.42 | |
| Normalized Basic EPS | -- | -- | -0.13 | -0.14 | |
| EPS Diluted | -- | -- | -0.40 | -0.42 | |
| Normalized Diluted EPS | -- | -- | -0.13 | -0.14 | |
| Average Basic Shares Outstanding | -- | -- | 278.57M | 278.02M | |
| Average Diluted Shares Outstanding | -- | -- | 278.57M | 278.02M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |